AtaiBeckley shares jumped 50% in premarket trading after reports said Eli Lilly is in advanced talks to acquire the psychedelic drug developer. Analysts estimate the deal could be worth more than $2 billion if completed.
AtaiBeckley shares jumped 50% in premarket trading after reports said Eli Lilly is in advanced talks to acquire the psychedelic drug developer. Analysts estimate the deal could be worth more than $2 billion if completed.
<iframe src="https://hindustansphere.com/embed/cluster/05628aad9b88cda624e19b58a4fec1c0d0fb8df9" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="AtaiBeckley Shares Surge 50% On Report Of Eli Lilly Eyeing Psychedelic Drug Developer's Acquisition"></iframe>
